A 50-Year-Old Patient with Guillain–Barré Syndrome after COVID-19: A Case Report
Open Access
- 29 July 2021
- Vol. 57 (8), 775
- https://doi.org/10.3390/medicina57080775
Abstract
Severe acute respiratory syndrome coronavirus 2, or SARS-CoV-2, causes acute respiratory disease (coronavirus disease 2019; COVID-19). However, the involvement of other mechanisms is also possible, and neurological complications are being diagnosed more frequently. Here, we would like to present a case of a Polish patient with Guillain–Barré syndrome (GBS), after a documented history of COVID-19: A 50-year-old man, 18 days after the onset of COVID-19 symptoms, had progressive quadriparesis preceded by 1-day sensory disturbances. Based on the clinical picture, the results of diagnostic work-up including a nerve conduction study (ENG) that revealed a demyelinating and axonal sensorimotor polyneuropathy, and cerebrospinal fluid (CSF) analysis that showed albumin–cytological dissociation, an acute inflammatory demyelinating polyneuropathy was confirmed, consistent with GBS. Upon a therapeutic plasma exchange (TPE), the patient’s condition improved. The presented case of GBS in a patient after mild COVID-19 is the first case in Poland that has supplemented those already described in the global literature. Attention should be drawn to the possibility of GBS occurring after SARS-CoV-2 infection, even when it has a mild course.Keywords
This publication has 25 references indexed in Scilit:
- Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, ChinaJAMA Neurology, 2020
- SARS-CoV-2: a storm is ragingJCI Insight, 2020
- Clinical features of patients infected with 2019 novel coronavirus in Wuhan, ChinaThe Lancet, 2020
- 0.9% saline versus Plasma-Lyte as initial fluid in children with diabetic ketoacidosis (SPinK trial): a double-blind randomized controlled trialCritical Care, 2020
- Diagnosis and management of Guillain–Barré syndrome in ten stepsNature Reviews Neurology, 2019
- Neurological Complications during Treatment of Middle East Respiratory SyndromeJournal of Clinical Neurology, 2017
- Guillain-Barré syndromeThe Lancet, 2016
- Antiganglioside antibodies are associated with axonal Guillain–Barré syndrome: A Japanese–Italian collaborative studyJournal of Neurology, Neurosurgery & Psychiatry, 2011
- Neurological manifestations in severe acute respiratory syndrome.2005
- Peripheral neuropathies and anti-glycolipid antibodiesBrain, 2002